Candela Corporation announces that the Profound microneedling treatment has been named “New Treatment of the Year” by The Global Aesthetic Awards, also known as MyFaceMyBody Awards USA.
The Profound system is a radiofrequency (RF) microneedling device that is designed to use real-time temperature control to yield predictable outcomes and is FDA-cleared for the treatment of facial wrinkles and improvements in the appearance of cellulite.
MyFaceMyBody Awards celebrates the innovation and customer excellence within the aesthetics industry. The awards honor leaders in aesthetics and brands for their product innovation and popularity. Hundreds of applications from across the United States are received, and category winners are elected from consumer and industry votes, according to a media release from Candela.
“We are pleased to provide solutions for the treatments and outcomes consumers and the industry are seeking. Over 3 million Americans had a nonsurgical aesthetic treatment in 2017, and this award is a testament to the growing demand for the Profound treatment’s clinically proven results and the patient satisfaction achieved with the device’s unique patented technology,” says Mary Trout, chief commercial officer, Candela, in the release.
“The Profound treatment is clinically proven to create up to five times the elastin, twice the collagen, and increased hyaluronic acid during nonsurgical treatment, enabling practitioners to offer long lasting outcomes and provide their patients with a trusted, natural alternative to dermal injectables and surgery.”
The Profound system uses patented technology to deliver RF energy to induce the body’s natural healing response to regenerate new collagen, elastin and hyaluronic acid, without toxins or fillers. The real-time and continuously monitored, temperature-controlled device allows practitioners to determine how much energy is delivered, as well as achieve and maintain a therapeutic temperature level.
[Source(s): Candela, PR Newswire]